Johnson & Johnson connected to Synthes Swiss drugmaker Roche has reached a deal with Genentech to acquire all of the shares in the US biotech group that it does not already own.
Over the last nine months Genentech has repeatedly rejected Roche’s attempts to buy the 44 percent of shares saying the price offered undervalued the company. Now Genentech’s board is recommending shareholders accept the latest increased cash offer. Roche is paying the equivalent of 36.5 billion euros.More about: Pharmaceutical companies, SwitzerlandCopyright © 2012 euronews
Top Stories
Greek coalition closer to agreement on bailout terms
After spending most of the day in talks with prime minister Lucas Papademos, Greece’s coalition party leaders have made some headway. They have agreed to all but one of the points negotiated with the troika of IMF and EU negotiators for the much-needed one hundred and thirty billion euro bailout…
Problems helping the injured in Syria
In addition to the 100 people said to have been killed in Homs on Wednesday, there are also…
Capello quits as England boss
England football manager, Fabio Capello has resigned. The Football Association released a…
Corporate news
Some shareholders baulk at Glencore-Xstrata merger- Upbeat forecast from Toyota
- Gloomy outlook from UBS
- Boeing plays down 787 delamination problem
- Mitsubishi puts the brakes on European production
- Panasonic joins Sony and Sharp in sea of red ink
- Debt grounds Hungary’s Malev
- Can you dig it? Xstrata Glencore merger talks
- Facebook to sell shares, but Zuckerberg stay in control
- Facebook files for market flotation
euronews on facebook
